ArticleInternational journal of hematology2017

CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.

Maki Yokoyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.